NO2891663T3 - - Google Patents
Info
- Publication number
- NO2891663T3 NO2891663T3 NO13833212A NO13833212A NO2891663T3 NO 2891663 T3 NO2891663 T3 NO 2891663T3 NO 13833212 A NO13833212 A NO 13833212A NO 13833212 A NO13833212 A NO 13833212A NO 2891663 T3 NO2891663 T3 NO 2891663T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012191050 | 2012-08-31 | ||
| PCT/JP2013/073084 WO2014034754A1 (ja) | 2012-08-31 | 2013-08-29 | Psf1由来ペプチド |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2891663T3 true NO2891663T3 (pl) | 2018-05-19 |
Family
ID=50183559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13833212A NO2891663T3 (pl) | 2012-08-31 | 2013-08-29 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US9683016B2 (pl) |
| EP (1) | EP2891663B8 (pl) |
| JP (1) | JP5920742B2 (pl) |
| DK (1) | DK2891663T3 (pl) |
| ES (1) | ES2662808T3 (pl) |
| HU (1) | HUE036243T2 (pl) |
| NO (1) | NO2891663T3 (pl) |
| PT (1) | PT2891663T (pl) |
| WO (1) | WO2014034754A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111518216B (zh) * | 2019-02-02 | 2024-02-02 | 上海细胞治疗集团有限公司 | 多肽、含有多肽的组合物及其在肿瘤免疫中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| WO2003033675A2 (en) * | 2001-10-19 | 2003-04-24 | Dgi Bio Technologies, Inc. | Identification of binding partners for specific proteins |
| WO2003042661A2 (en) | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| GB0518877D0 (en) * | 2005-09-15 | 2005-10-26 | Medical Res Council | Markers and methods |
| JPWO2007119515A1 (ja) * | 2006-03-28 | 2009-08-27 | 昇志 佐藤 | 新規腫瘍抗原ペプチド |
| TWI615403B (zh) * | 2007-02-21 | 2018-02-21 | 腫瘤療法 科學股份有限公司 | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
| CN102482348B (zh) | 2009-09-16 | 2014-08-27 | 盐野义制药株式会社 | 胶原新表位抗体 |
-
2013
- 2013-08-29 NO NO13833212A patent/NO2891663T3/no unknown
- 2013-08-29 HU HUE13833212A patent/HUE036243T2/hu unknown
- 2013-08-29 WO PCT/JP2013/073084 patent/WO2014034754A1/ja not_active Ceased
- 2013-08-29 US US14/424,981 patent/US9683016B2/en not_active Expired - Fee Related
- 2013-08-29 PT PT138332127T patent/PT2891663T/pt unknown
- 2013-08-29 JP JP2014533063A patent/JP5920742B2/ja not_active Expired - Fee Related
- 2013-08-29 DK DK13833212.7T patent/DK2891663T3/en active
- 2013-08-29 EP EP13833212.7A patent/EP2891663B8/en active Active
- 2013-08-29 ES ES13833212.7T patent/ES2662808T3/es active Active
-
2017
- 2017-01-23 US US15/413,343 patent/US9919039B2/en not_active Expired - Fee Related
-
2018
- 2018-02-07 US US15/891,238 patent/US10617750B2/en not_active Expired - Fee Related
-
2020
- 2020-03-11 US US16/815,068 patent/US20200206330A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US9683016B2 (en) | 2017-06-20 |
| US20150218216A1 (en) | 2015-08-06 |
| US20170173133A1 (en) | 2017-06-22 |
| JPWO2014034754A1 (ja) | 2016-08-08 |
| EP2891663B8 (en) | 2018-04-04 |
| PT2891663T (pt) | 2018-03-20 |
| HUE036243T2 (hu) | 2018-06-28 |
| US10617750B2 (en) | 2020-04-14 |
| EP2891663B1 (en) | 2017-12-20 |
| US20180169203A1 (en) | 2018-06-21 |
| US9919039B2 (en) | 2018-03-20 |
| US20200206330A1 (en) | 2020-07-02 |
| EP2891663A1 (en) | 2015-07-08 |
| DK2891663T3 (en) | 2018-03-26 |
| JP5920742B2 (ja) | 2016-05-18 |
| EP2891663A4 (en) | 2016-04-13 |
| ES2662808T3 (es) | 2018-04-09 |
| WO2014034754A1 (ja) | 2014-03-06 |